Effectiveness of immunosuppressive therapy in older patients with aplastic anemia

Annals of Internal Medicine

Volumn 130, Issue 3, 1999, Pages 193-201

  Tichelli, André ^a   Socié, Gérard ^b   Henry Amar, Michel ^c   Marsh, Judith ^d   Passweg, Jakob ^a   Schrezenmeier, Hubert ^e   McCann, Shaun ^f   Hows, Jill ^g   Ljungman, Per ^h   Marin, Pedro ⁱ   Raghavachar, Aruna ^e   Locasciulli, Anna ^j   Gratwohl, Alois ^a   Bacigalupo, Andrea ^k  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SAINT LOUIS HOSPITAL   (France)

^c CENTRE FRANÇOIS BACLESSE   (France)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ULM   (Germany)

^f ST JAMES S HOSPITAL   (Ireland)

^g NORTH BRISTOL NHS TRUST   (United Kingdom)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ Farreras Valenti   (Spain)

^j SAN GERARDO HOSPITAL   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LYMPHOCYTE ANTIBODY;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CLONAL ANERGY; COHORT ANALYSIS; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0033514487     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-3-199902020-00004     Document Type: Article

References (34)

1. Bacigalupo A, Chaple A, Hows J, Van Lint MT, McCann S, Milligan D, et al. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens a randomized trial from the EBMT SAA working party. Br J Haematol. 1993;83:145-51.
2. Speck B, Gratwohl A, Nissen C, Osterwalder B, Würsch A, Tichelli A, et al. Treatment of severe aplastic anemia. Exp Hematol. 1986;14:126-32.
3. Young NS, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A, et al. A muiticenter trial of antilymphocyte globulin in aplastic anemia and related diseases. Blood. 1988;72:1861-9.
4. Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, et al. Long-term follow-up of allogeneic narrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin [Letter]. Blood. 1997;89:3890-1.
5. Klingemann HG, Storb R, Fefer A, Deeg HJ, Appelbaum F, Buckner CD, et al. Bone marrow transplantation in patients aged 45 years and older. Blood. 1986;67:770-6.
6. Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992;79:269-75.
7. Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood. 1997;90:858-64.
8. Deeg HJ, Leisenring W, Storb R, Nims J, Flowers ME, Witherspoon RP, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637-45.
9. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995; 85:283-90.
10. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Ragavashar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991;324:1297-304.
11. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D, et al. Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood. 1992;79:2540-6.
12. Marsh JC, Hows JM, Bryett KA, Al-Hashimi S, Fairhead SM, Gordon-Smith EC. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood. 1987;70:1046-52.
13. Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol. 1993;85:371-7.
14. Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. 5Blood. 1995;85:3367-77.
15. Nissen C, Gratwohl A, Tichelli A, Stebler C, Wursch A, Moser Y, et al. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia. Br J Haematol. 1993;83:319-25.
16. de Planque MM, Kluin-Nelemans HC, van Krieken HJ, Kluin PM, Brand A, Beverstock GC, et al. Evolution of acquired severe aplastic anaemia to myelodysplastic and subsequent leukaemia in adults. Br J Haematol. 1988;70: 55-62.
17. Najean Y, Haguenauer O. Long-term (5 to 20 years) evolution of non-grafted aplastic anemias. The Cooperative Group for the Study of Aplaslic and Refractory Anemias. Blood 1990;76:2222-8.
18. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997; 90:1009-13.
19. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152-7.
20. Tichelli A, Gratwohl A, Würsch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988;69:413-8.
21. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79:1385-92.
22. Camitta B, O'Reilly RJ, Sensenbrenner L, Rappeport J, Champlin R, Doney K, et al. Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood. 1983;62:883-8.
23. Reiter E, Keil F, Brugger S, Kalhs P, Rabitsch W, Hinterberger W, et al. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia. Bone Marrow Transplant. 1997;19:1191-6.
24. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D, et al. Multicenter randomized study comparing cyclasponne-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood. 1992;79:2540-6.
25. Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med. 1997;126:107-15.
26. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, van Lint MT, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia: a report of the EBMT SAA Working Party. Br J Haematol. 1988;70:177-82.
27. de Planque MM, Bacigalupo A, Würsch A, Hows J, Devergie A, Frickhofen N, et al. Long-term follow-up of severe aplastic anaemia patients treated with antilymphocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation. Br J Haematol. 1989;73:121-6.
28. Marsh JC, Geary CG. Is aplastic anaemia a pre-leukaemic disorder? [Editorial] Br J Haematol. 1991;77:447-52.
29. Tichelli A, Gratwohl A, Nissen C, Speck B. Late clonal complications in severe aplastic anemia. Leuk Lymphoma. 1994;12:167-75.
30. Orazi A, Albitar M, Heerema NA, Haskins S, Neiman RS. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol. 1997;107:268-74.
31. Yamazaki E, Kanamori H, Taguchi J, Harano H, Mohri H, Okubo T. The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction. Blood Cells Mol Dis. 1997;23:213-8.
32. Champlin RE, Ho WG, Feig SA, Winston DJ, Lenarsky C, Gale RP. Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood. 1985;66:184-8.
33. Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum FR, et al. Immunosuppressive treatment of aplastic anemia: results of a prospective, randomized trial of antilymphocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood. 1992;79:2566-71.
34. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party Blood. 1995;85:1348-53.